Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Alligator Bioscience AB
AB
Active
Org 5565978201
Scheelevägen 2, 223 63
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2000 · 25 years old
10-19 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Alligator Bioscience AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
17M
33M
50M
67M
4M
2020
13M
2021
36M
2022
58M
2023
58M
2024
EBITDA
SEK millions
0M
-78M
-155M
-233M
-310M
-139M
2020
-137M
+1%
2021
-189M
-38%
2022
-248M
-31%
2023
-234M
+6%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
4 352
12 943
36 000
58 000
57 767
Staff expenses
—
—
—
—
—
EBITDA
−138 872
−136 718
−189 000
−248 000
−234 064
Depreciation & amort.
−5 658
−5 084
−4 000
−1 000
−961
EBIT
−144 530
−141 802
−193 000
−249 000
−235 025
Net financials
14 823
35
—
1 000
2 925
Profit before tax
−129 270
−141 765
−193 000
−248 000
−231 002
Tax
−0
−0
−0
−0
−0
Net profit
−129 270
−141 765
−193 000
−248 000
−231 002
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
142 038
326 488
148 000
105 000
104 568
Equity
117 416
284 424
91 000
14 000
−125 697
Long-term debt
432
143
0
0
0
Short-term debt
24 190
41 921
57 000
91 000
191 586
Total debt
24 622
42 064
57 000
91 000
191 586
Financial ratios
5-year trend
EBITDA margin
-405.2%
This company
15.8%
Market median
-2665% vs market
2020
2024
Equity ratio
-120.2%
This company
38.2%
Market median
-415% vs market
2020
2024
Return on equity
-23100200000.0%
This company
18.4%
Market median
-125544565317% vs market
2020
2024
Net profit margin
-399.9%
This company
8.1%
Market median
-5037% vs market
2020
2024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
2020
2024
Debt / equity
1.83×
This company
0.62×
Market median
-195% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Alligator Bioscience AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
